SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for discovery and translational research, today announced that Todd Garland has been appointed Chief Commercial Officer, effective August 28, 2023. Mr. Garland is a senior executive with more than 25 years of experience in healthcare and life sciences technologies that serve customers in […]
Sales Organization Enhanced, Platform Organization Created FREMONT, Calif. — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the appointment of Philippe Busque, Ph.D. as Senior Vice President of Global Sales & Services. In this newly created position, Dr. Busque will lead an enhanced global sales organization encompassing all customer facing functions […]
San Jose, CA (USA) & Hamburg (Germany) — Takara Bio Inc. (Takara Bio) and Eppendorf SE, two renowned leaders in the life science industry, are pleased to announce their collaboration through a strategic co-marketing agreement. This partnership aims at jointly developing cutting-edge solutions to automate Takara Bio’s chemistries on Eppendorf epMotion® automation platforms. “The integration […]
DURHAM, NORTH CAROLINA, UNITED STATES — Cell Microsystems, a provider of pioneering solutions for cell biology research, is excited to announce the acquisition of Fluxion Biosciences, a leader in automated patch clamp technology and cell-based assay tools. This acquisition complements the Company’s platforms and applications based on the CellRaft technology, enhancing its offerings for researchers and […]
Results generated to date serve as basis for new IP filings and conference presentations, and have led to an expansion of the collaboration beyond CAR T cells SAN FRANCISCO — Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, today announced it has achieved key milestones in its R&D collaboration with Labcorp, […]
Synthego to develop multiplexed and complex genetic engineering strategies, increasing the safety and speed at which bit.bio can engineer human cells for cell therapies. bit.bio aims to leverage technology to increase efficiency of human cell engineering and accelerate the development of highly scalable cell therapies that are capable of treating millions of patients. Redwood City, […]
Rentschler Biopharma, Cell and Gene Therapy Catapult and Refeyn announce collaboration The collaborators will use automated and digital technologies to improve the process of manufacturing adeno-associated viruses (AAV) Stevenage and London, UK, and Laupheim, Germany– Rentschler Biopharma, a leading global contract development and manufacturing organisation (CDMO) for biopharmaceuticals, including advanced therapy medicinal products (ATMPs), announces a […]
SEATTLE — Curi Bio, the industry leader in developing human stem cell-based platforms for drug discovery, proudly announces two recent SBIR grants worth $4.4 million from the National Institutes of Health (NIH) to support its pioneering work on implementing human models to advance discovery of the next generation of medicines. The first project will support […]
Pleasanton, CA – Unchained Labs, the life science tools company that’s all about getting biologics and gene therapy researchers the right tools for the job, announced today that life sciences ace, Scott Thomas, has joined the Company as Chief Commercial Officer. Scott has some serious street cred when it comes to scaling life science commercial […]
BICO Group AB (publ) announces that Erik Gatenholm, after initiating discussions with the Board of Directors, has decided to step down as President and CEO of BICO Group. Maria Forss has been appointed new President and CEO. Maria Forss will assume office on November 27, 2023, or sooner. Maria Forss has been appointed new President […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
